Special Bulletin
The American Hospital Association (AHA) sends members Special Bulletins on the latest health care news, legislation, and advocacy opportunities for hospitals and health systems.
The Centers for Medicare & Medicaid Services (CMS) July 11 issued a proposed rule that would update the home health (HH) prospective payment system (PPS) for calendar year (CY) 2020. In accordance with the statutory mandate in the Bipartisan Budget Act of 2018 (BBA of 2018), last year’s…
The Centers for Medicare & Medicaid Services (CMS) July 10 issued a proposed rule that would establish a new alternative payment model (APM) for radiation oncology (RO) services delivered to Medicare fee-for-service (FFS) beneficiaries. The RO model would test whether prospective, bundled…
The Centers for Medicare & Medicaid Services’ (CMS) Center for Medicare and Medicaid Innovation (CMMI) July 10 announced five new CMMI payment models aimed at transforming kidney care so that patients with chronic kidney disease have access to high-quality, coordinated care. The proposed End-…
The White House June 24 released an executive order on “improving price and quality transparency in American health care.” The executive order focuses on five policies:
The Senate Committee on Health, Education, Labor and Pensions (HELP) released a revised version of the Lower Health Care Costs Act of 2019 (S.1895) – bipartisan legislation focused on reducing health care costs.
The Departments of Labor, Health and Human Services, and the Treasury (collectively, the departments) recently finalized new rules related to how employers may use health reimbursement arrangements (HRAs) to provide health coverage to employees. In particular, the rule expands the uses of HRAs to…
Leaders of the Senate Committee on Health, Education, Labor and Pensions (HELP) May 23 released the Lower Health Care Costs Act of 2019 – bipartisan discussion draft legislation focused on reducing health care costs.
The Centers for Medicare & Medicaid Services May 16 released a final rule with the intent of lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.
The Centers for Medicare & Medicaid Services (CMS) today released a final rule aimed at increasing drug price transparency and reducing the price of prescription drugs and biological products for consumers.
The Department of Health and Human Services (HHS) Office for Civil Rights May 2 issued a final rule concerning federal health care-related conscience protections applicable to programs funded or administered by HHS (e.g., Medicare, Medicaid or grant programs).